Literature DB >> 27920255

The MLKL Channel in Necroptosis Is an Octamer Formed by Tetramers in a Dyadic Process.

Deli Huang1, Xinru Zheng1, Zi-An Wang1, Xin Chen1, Wan-Ting He1, Yingying Zhang1, Jin-Gen Xu2, Hang Zhao1, Wenke Shi1, Xin Wang1, Yongqun Zhu2, Jiahuai Han3.   

Abstract

Oligomerization of the mixed-lineage kinase domain-like protein (MLKL) is essential for its cation channel function in necroptosis. Here we show that the MLKL channel is an octamer comprising two previously identified tetramers most likely in their side-by-side position. Intermolecule disulfide bonds are present in the tetramer but are not required for octamer assembly and necroptosis. MLKL forms oligomers in the necrosome and is then released from the necrosome before or during its membrane translocation. We identified two MLKL mutants that could not oligomerize into octamers, although they formed a tetramer, and also, one MLKL mutant could spontaneously form a disulfide bond-linked octamer. Subsequent analysis revealed that the tetramers fail to translocate to the plasma membrane and that the MLKL octamer formation depends on α-helices 4 and 5. While MLKL could be detected from outside the cells, its N- and C-terminal ends could not be detected, indicating that the MLKL octamer spans across the plasma membrane, leaving its N and C termini inside the cell. These data allowed us to propose a 180° symmetry model of the MLKL octamer and conclude that the fully assembled MLKL octamers, but not the previously described tetramers, act as effectors of necroptosis.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  MLKL; channel; necroptosis; octamer

Mesh:

Substances:

Year:  2017        PMID: 27920255      PMCID: PMC5311246          DOI: 10.1128/MCB.00497-16

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation.

Authors:  Marion C Bonnet; Daniela Preukschat; Patrick-Simon Welz; Geert van Loo; Maria A Ermolaeva; Wilhelm Bloch; Ingo Haase; Manolis Pasparakis
Journal:  Immunity       Date:  2011-10-13       Impact factor: 31.745

2.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.

Authors:  James M Murphy; Peter E Czabotar; Joanne M Hildebrand; Isabelle S Lucet; Jian-Guo Zhang; Silvia Alvarez-Diaz; Rowena Lewis; Najoua Lalaoui; Donald Metcalf; Andrew I Webb; Samuel N Young; Leila N Varghese; Gillian M Tannahill; Esme C Hatchell; Ian J Majewski; Toru Okamoto; Renwick C J Dobson; Douglas J Hilton; Jeffrey J Babon; Nicos A Nicola; Andreas Strasser; John Silke; Warren S Alexander
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

3.  Ppm1b negatively regulates necroptosis through dephosphorylating Rip3.

Authors:  Wanze Chen; Jianfeng Wu; Lisheng Li; Zhengmao Zhang; Junming Ren; Yaoji Liang; Fenfang Chen; Chao Yang; Zhenru Zhou; Sheng Sean Su; Xinru Zheng; Zhirong Zhang; Chuan-Qi Zhong; Haoqiang Wan; Mu Xiao; Xia Lin; Xin-Hua Feng; Jiahuai Han
Journal:  Nat Cell Biol       Date:  2015-03-09       Impact factor: 28.824

4.  The binding of sodium dodecyl sulphate to various proteins.

Authors:  R Pitt-Rivers; F S Impiombato
Journal:  Biochem J       Date:  1968-10       Impact factor: 3.857

5.  Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis.

Authors:  X-N Wu; Z-H Yang; X-K Wang; Y Zhang; H Wan; Y Song; X Chen; J Shao; J Han
Journal:  Cell Death Differ       Date:  2014-06-06       Impact factor: 15.828

6.  Sequential Engagement of Distinct MLKL Phosphatidylinositol-Binding Sites Executes Necroptosis.

Authors:  Giovanni Quarato; Cliff S Guy; Christy R Grace; Fabien Llambi; Amanda Nourse; Diego A Rodriguez; Randall Wakefield; Sharon Frase; Tudor Moldoveanu; Douglas R Green
Journal:  Mol Cell       Date:  2016-02-04       Impact factor: 17.970

7.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.

Authors:  Marius Dannappel; Katerina Vlantis; Snehlata Kumari; Apostolos Polykratis; Chun Kim; Laurens Wachsmuth; Christina Eftychi; Juan Lin; Teresa Corona; Nicole Hermance; Matija Zelic; Petra Kirsch; Marijana Basic; Andre Bleich; Michelle Kelliher; Manolis Pasparakis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

8.  MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates.

Authors:  Yves Dondelinger; Wim Declercq; Sylvie Montessuit; Ria Roelandt; Amanda Goncalves; Inge Bruggeman; Paco Hulpiau; Kathrin Weber; Clark A Sehon; Robert W Marquis; John Bertin; Peter J Gough; Savvas Savvides; Jean-Claude Martinou; Mathieu J M Bertrand; Peter Vandenabeele
Journal:  Cell Rep       Date:  2014-05-09       Impact factor: 9.423

9.  A plug release mechanism for membrane permeation by MLKL.

Authors:  Lijing Su; Bradley Quade; Huayi Wang; Liming Sun; Xiaodong Wang; Josep Rizo
Journal:  Structure       Date:  2014-09-11       Impact factor: 5.006

10.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

View more
  49 in total

1.  Herpes simplex virus 1 ICP6 impedes TNF receptor 1-induced necrosome assembly during compartmentalization to detergent-resistant membrane vesicles.

Authors:  Mohammad Ali; Linda Roback; Edward S Mocarski
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

Review 2.  Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.

Authors:  Holly Anderton; Ian P Wicks; John Silke
Journal:  Nat Rev Rheumatol       Date:  2020-07-08       Impact factor: 20.543

3.  Knocking 'em Dead: Pore-Forming Proteins in Immune Defense.

Authors:  Xing Liu; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2020-01-31       Impact factor: 28.527

4.  MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis.

Authors:  Shuzhen Liu; Hua Liu; Andrea Johnston; Sarah Hanna-Addams; Eduardo Reynoso; Yougui Xiang; Zhigao Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

Review 5.  Structural Insights into the Plant Immune Receptors PRRs and NLRs.

Authors:  Jizong Wang; Jijie Chai
Journal:  Plant Physiol       Date:  2020-02-11       Impact factor: 8.340

6.  Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites.

Authors:  Dan E McNamara; Cole M Dovey; Andrew T Hale; Giovanni Quarato; Christy R Grace; Cristina D Guibao; Jonathan Diep; Amanda Nourse; Casey R Cai; Hong Wu; Ravi C Kalathur; Douglas R Green; John D York; Jan E Carette; Tudor Moldoveanu
Journal:  Cell Chem Biol       Date:  2019-04-25       Impact factor: 8.116

7.  Thioredoxin-1 actively maintains the pseudokinase MLKL in a reduced state to suppress disulfide bond-dependent MLKL polymer formation and necroptosis.

Authors:  Eduardo Reynoso; Hua Liu; Lin Li; Anthony L Yuan; She Chen; Zhigao Wang
Journal:  J Biol Chem       Date:  2017-09-06       Impact factor: 5.157

Review 8.  Initiation and execution mechanisms of necroptosis: an overview.

Authors:  Sasker Grootjans; Tom Vanden Berghe; Peter Vandenabeele
Journal:  Cell Death Differ       Date:  2017-05-12       Impact factor: 15.828

9.  Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis.

Authors:  Joseph K Rathkey; Junjie Zhao; Zhonghua Liu; Yinghua Chen; Jie Yang; Hannah C Kondolf; Bryan L Benson; Steven M Chirieleison; Alex Y Huang; George R Dubyak; Tsan S Xiao; Xiaoxia Li; Derek W Abbott
Journal:  Sci Immunol       Date:  2018-08-24

10.  Ceramide Nanoliposomes as a MLKL-Dependent, Necroptosis-Inducing, Chemotherapeutic Reagent in Ovarian Cancer.

Authors:  Xuewei Zhang; Kazuyuki Kitatani; Masafumi Toyoshima; Masumi Ishibashi; Toshinori Usui; Junko Minato; Mahy Egiz; Shogo Shigeta; Todd Fox; Tye Deering; Mark Kester; Nobuo Yaegashi
Journal:  Mol Cancer Ther       Date:  2017-10-27       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.